Summary
Previous studies have suggested the possibility that the non-steroidal antiflammatory drug (NSAID), ibuprofen, may inhibit thromboxane (TX) A2 synthase activity in addition to inhibiting cyclooxygenae activity. Microsomal fractions isolated from the cat lung contain cyclooxygenase as well as prostacyclin (PGI2) synthase, TX synthase, and a GSH-dependent prostaglandin (PG) E2 isomerase activities. When [1-14C] PG endoperoxide H2 (PGH2) was used as substrate, ibuprofen, indomethacin, and meclofenamate exhibited differential effects on terminal enzyme activities. Ibuprofen, at concentrations up to 1 mM, had no effect on the activities of PGI2 synthase, TXA2 synthase of GSH-dependent PGE2 isomerase, whereas indomethacin selectively inhibited PGI2 synthase activity at 5 x 10−4 M and 10−3 M. Meclofenamate selectively inhibited TXA2 synthase activity at 5 x 10−4 M and 10−3 M. At concentrations of 5 x 10−3 M, this selectivity was not oberved, and indomethacin and meclofenamate decreased the formation of both 6-keto-PGF1α and TXB2. These data indicate that the choice of NSAID and the concentration employed may specifically alter PGH2 metabolism. This action may affect the physiologic consequences of the exchange of PGH2 between cells. The data further indicate that indomethacin has the potential for use as a tool to specifically attenuate PGI2 synthase activity in vitro.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dawson CA: Role of pulmonary vasomotion in physiology of the lung. Physiol Rev 64:544–616, 1984
Malik AB: Pulmonary microembolism. Physiol Rev 63:1114–1207, 1983
Jacobs ER, Soulsby ME, Bone RC, Wilson FJ Jr, Hiller GF: Ibuprofen in canine endotoxin shock. J Clin Invest 70:536–541, 1982
Soulsby ME, Jacobs ER, Perlmutter BH, Bone RC: Protection of myocardial function during endotoxin shock by ibuprofen. Prostaglandins, Leukotrienes, Med 13:295–305, 1984
Ogletree ML, Brigham KL: Effects of cyclooxygenase inhibitors on pulmonary vascular responses to endotoxin in unanesthetized sheep. Prostaglandins, Leukotrienes, Med 8:489–502, 1982
Snapper JR, Hutchison AA, Ogletree ML, Brigham KL: Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J Clin Invest 72:63–76, 1983
Erman A, Schwartzman M, Raz A: Indomethacin but not aspirin inhibits basal stimulated lipolysis in rabbit kidney. Prostaglandins 20:689–702, 1980
Adams S, McCullough KF, Nicholson JS: The pharmacological properties of ibuprofen, an anti-inflammatory, analgesic and antipyretic. Arch int Pharmacodyn Ther 178:115–129, 1969
Shinozawa Y, Hales C, Jung W, Burke J: Ibuprofen prevents synthetic smoke-induced pulmonary edema. Am Rev Respir Dis 134:1145–1148, 1986
She HS, McNamara DB, Spannhake EW, Hyman AL, Kadowitz PJ: Metabolism of prostaglandin endoperoxide by microsomes from cat lung. Prostaglandins 21:531–541, 1981]
Ogino N, Miyamoto T, Yamamoto S, Hyaishi T: Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsome, a glutathione requiring enzyme. J Biol Chem 252:890–895, 1977
McNamara DB, Hussey JL, Kerstein MD, Rosenson RS, Hyman AL, Kadowitz PJ: Modulation of prostacyclin synthase and unmasking of PGE2 isomerase in bovine coronary arterial microsomes. Biochem Biophys Res Comm 118:33–39, 1984
Rush DS, Kerstein MD, Bellan JA, Knoop SM, Mayeux PR, Hyman AL, Kadowitz PJ, McNamara DB: Prostacyclin, thromboxane A2, and prostaglandin E2 formation in atherosclerotic human carotid artery. Arteriosclerosis 83:73–78, 1988
Marcus AJ, Weksler B, Jaffe EA, Broekman MJ: Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest 66:979–986, 1980
McNamara DB, Mayeux PR, Kerstein MD, Rush DS, Hyman AL, Kadowitz PJ: Prostacyclin (PGI2) formation dependency on endothelium: effect of platelets (Abstr.). Circulation 76:IV-471, 1987
Mayeux PR, Hyman AL, Kadowitz PJ, McNamara DB: Evidence for a bidirectional prostaglandin (PG) endoperoxide shunt between platelets and vascular tissue (Abstr.). Fed Proc 46:692, 1987
Mayeux PR, Kadowitz PJ, McNamara DB: Evidence for a bidirection prostaglandin endoperoxide shunt between platelets and bovine coronary artery. Biochim Biophys. Acta (in press), 1989
Smith EF III, Wise WC, Halushka PV, Cook JA: Macrophage eicosanoid formation is stimulated by platelet arachidonic acid and prostaglandin endoperoxide transfer. Biochim Biophys Acta 923:355–361, 1987
Hayden B, Soderberg R, Zarein H, Chandhuri G: Salvage of ischemic rabbit ear by BW-755c and steroids but not indomethacin. Prostaglandins 33:63–73, 1987
Brunkwall JS, Stanely JC, Graham LM, Burkel WE: Influence of pressure, flow rate, and pulsatility on release of 6-keto-PGF1α and thromboxane B2 in ex vivo-perfused canine veins. J Vasc Surg 7:99–107, 1988
Littner MR, Kazim GM, Lott FD: Distribution of cyclooxygenase inhibition in isolated dog lung. J Appl Physiol 63:988–993, 1986]
Raftar G, de Gaetano G: Tranylcypromine is not a selective inhibitor of prostacyclin in rats. Thromb Res 14:245–248, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mayeux, P.R., Kadowitz, P.J. & McNamara, D.B. Differential effects of ibuprofen, indomethacin, and meclofenamate on prostaglandin endoperoxide H2 metabolism. Mol Cell Biochem 87, 41–46 (1989). https://doi.org/10.1007/BF00421081
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00421081